Company intelligence / Profile preview

Fibralign

Union City, California, United Statesfibralignbio.com ↗

Ownership: Private
Development stage: Commercial

Overview

Fibralign has commercialized the BioBridge Collagen Matrix—a novel biomaterial device cleared by the FDA and CE-marked for soft tissue repair. It’s being clinically studied as an adjunct to surgery to treat or prevent secondary lymphedema. Early results from animal studies with Stanford validated its efficacy in lymphatic tissue regeneration. Multi-site clinical trials are ongoing in the US and Europe targeting breast cancer-related acquired lymphedema. The company’s proprietary Nanoweave® technology underpins a broader pipeline of regenerative medicine products.

Therapeutic areas: OncologyCardiovascularOther
Modalities: DeviceBiomaterial (Collagen matrix)Nanoweave-based scaffold technology
Industry: Implantable Medical Devices

Drug pipeline

1 asset

BioBridge

Commercial

Indications: Soft tissue repair, Secondary lymphedema (investigational)

Partnerships

Terumo Corporation (European/Japan clinical studies sponsor)Stanford University research collaborationsJLABS@SSF alumnusUCSF Rosenman Institute Innovator cohort member

Beyond the preview

Go deeper on Fibralign.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fibralign.

Explore the full profile